Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM3101 to Augment Meniscal Healing
NCT05560477Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Apr 2023
- Primary completion
- Sep 2026
- Modality
- Injectable Hydrogels, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of AM3101 in Meniscus Tear (MT), sponsored by University of Cincinnati. Started Apr 2023; status: completed.
02
Drugs
AM3101
03
Conditions
Meniscus Tear (MT)
Beyond the preview
Go deeper on NCT05560477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05560477.